Tang Capital

Tang Capital Management, LLC is an investment firm focused on the life sciences sector, specializing in the strategic acquisition and restructuring of biotechnology companies. Its core approach involves identifying and acquiring undervalued entities to optimize their assets. This strategy often includes divesting intellectual property, aiming to generate investor returns.

The firm was established in 2002 by Kevin Tang. His founding insight centered on capitalizing on inherent, often unrealized, value within biotech companies facing financial or operational challenges. This involves methodically evaluating distressed assets and implementing clear strategies to extract and return capital.

Tang Capital's activities primarily serve shareholders by systematically realizing intrinsic value from promising therapeutic assets in acquired enterprises. The firm’s vision centers on efficiently deploying capital into niche opportunities across the life sciences industry, maintaining a disciplined approach to asset management and value creation.